Disease course and late sequelae of Langerhans' cell Histiocytosis: 25- year experience at the University of California, San Francisco

Journal of Clinical Oncology

Volumn 14, Issue 7, 1996, Pages 2073-2082

  Willis, B ^a   Ablin, A ^a   Weinberg, V ^a   Zoger, S ^a   Wara, W M ^a   Matthay, K K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER INCIDENCE; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CHILD; DIABETES INSIPIDUS; GROWTH DISORDER; HEARING LOSS; HISTIOCYTOSIS X; HUMAN; HYPOTHYROIDISM; INFANT; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; SKELETON MALFORMATION; UNITED STATES;

EID: 0029975753     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.7.2073     Document Type: Article

References (52)

1. Willman CL, Busque L, Griffith BB, et al: Langerhans'-cell histiocytosis (histiocytosis X)-A clonal proliferative disease. N Engl J Med 331:154-160, 1994
2. Chu T, D'Angio GJ, Favara B, et al: Histiocytosis syndromes in children. Lancet 306:208-209, 1987
3. Ladisch S, Jaffe ES: The histiocytoses, in Pizzo PA, Poplack DG (eds): Principles and Practice of Pediatric Oncology (ed 2). Philadelphia, PA, Lippincott, 1993, pp 617-631
4. Gianotti F, Caputo R: Histiocytic syndromes: A review. J Am Acad Dermatol 13:383-404, 1985
5. Cline MJ: Histiocytes and histiocytosis. Blood 84:2840-2853, 1994
6. Greenberger JS, Crocker AC, Vawter G, et al: Results of treatment of 127 patients with systemic histiocytosis. Medicine (Baltimore) 60:311-338, 1981
7. Raney RB, D'Angio GJ: Langerhans' cell histiocytosis (histiocytosis X): Experience at the Children's Hospital of Philadelphia, 1970-1984. Med Pediatr Oncol 17:20-28, 1989
8. Leavey P, Varughese M, Breatnach F, et al: Langerhans cell histiocytosis-A 31 year review. Irish J Med Sci 271-274, 1991
9. Gadner H, Heitger A, Grois N, et al: Treatment strategy for disseminated Langerhans cell histiocytosis. Med Pediatr Oncol 23:72-80, 1994
10. Sessa S, Sommelet D, Lascombes P, et al: Treatment of Langerhans-cell histiocytosis in children. J Bone Joint Surg 76-A:1513-1525, 1994
11. Lahey ME: Prognosis in reticuloendotheliosis in children. Pediatrics 60:664-671, 1962
12. Lahey ME: Prognostic factors in histiocytosis X. Am J Pediatr Hematol Oncol 3:57-60, 1981
13. Broadbent V: Favourable prognostic features in histiocytosis X: Bone involvement and absence of skin disease. Arch Dis Child 61:1219-1221, 1986
14. Minehan KJ, Chen MG, Zimmerman D, et al: Radiation therapy for diabetes insipidus caused by Langerhans cell histiocytosis. Int J Radiat Oncol Biol Phys 23:519-524, 1992
15. Greenberger JS, Cassady JR, Jaffe N, et al: Radiation therapy in patients with histiocytosis: Management of diabetes insipidus and bone lesions. Int J Radiat Oncol Biol Phys 5:1749-1755, 1979
16. Seleh MT, Parker RG: Radiation therapy in the management of Langerhans cell histiocytosis. Med Pediatr Oncol 18:97-102, 1990
17. Womer RB, Raney RB, D'Angio GJ: Healing rates of treated and untreated bone lesions in histiocytosis X. Pediatrics 76:286-288, 1985
18. Lahey ME: Histiocytosis X - A comparison of three treatment regimens. Pediatrics 87:179-183, 1975
19. Osband ME: Histiocytosis X. Langerhans' cell histiocytosis. Hematol Oncol Clin North Am 1:737-751, 1987
20. Greinix HT, Storb R, Sanders JE, et al: Marrow transplantation for treatment of multisystem progressive Langerhans cell histiocytosis. Bone Marrow Transplant 10:39-44, 1992
21. Egeler RM, de Kraker J, Voute PA: Cytosine-arabinoside, vincristine, and prednisolone in the treatment of children with disseminated Langerhans cell histiocytosis with organ dysfunction: Experience at a single institution. Med Pediatr Oncol 21:265-270, 1993
22. Broadbent V, Pritchard J, Yeomans E: Etoposide in the treatment of multisystem Langerhans cell histiocytosis. Med Pediatr Oncol 17:97-100, 1989
23. Thomas L, Ducros B, Secchi T, et al: Successful treatment of adult's Langerhans cell histiocytosis with thalidomide. Arch Dermatol 129:1261-1264, 1993
24. Longaker MA, Frieden IJ, LeBoit PE, et al: Congenital "self-healing" Langerhans cell histiocytosis: The need for long term follow-up. J Am Acad Dermatol 31:910-916, 1994
25. Egeler RM, D' Angio GJ: Langerhans cell histiocytosis. J Pediatr 127:1-11, 1995
26. Ladisch S, Gadner H: Treatment of langerhans cell histiocytosis - Evolution and current approaches. Br J Cancer 23:541-546, 1995
27. Hage C, Willman C, Favara B, et al: Langerhans cell histiocytosis: Immunophenotype and growth fraction. Hum Pathol 24:840-845, 1993
28. Kelly K, Pritchard J, Gordon I, et al: CD1 antibody immunolocalisation in Langerhans cell histiocytosis. Lancet 342:367-368, 1993
29. Kruskal WH, Wallis WA: Use of ranks in one-criterion variance analysis. J Am Stat Assoc 47:583-621, 1952
30. Dunn OJ: Multiple comparisons using rank sums. Technometrics 6:241-252, 1964
31. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
32. Peto R, Peto J: Asymptotically efficient rank invariant procedures. J R Stat Soc A 135:185-207, 1972
33. Greis PE, Hankin FM: Eosinophilic granuloma: The management of solitary lesions of bone. Clin Orthop Rel Res 25:204-211, 1988
34. Dunger DB, Broadbent V, Yeoman E, et al: The frequency and natural history of diabetes insipidus in children with Langerhans cell histiocytosis. N Engl J Med 321:1157-1162, 1989
35. Grois N, Barkovich AJ, Rosenau W, et al: Central nervous system disease associated with Langerhans cell histiocytosis. Am J Pediatr Hematol Oncol 15:245-254, 1993
36. Braunstein GD, Kohler PO: Endocrine manifestations of histiocytosis. Am J Pediatr Hematol Oncol 3:67-75, 1981
37. Ha SY, Helms P, Fletcher M, et al: Lung involvement in Langerhans' cell histiocytosis: Prevalence, clinical features, and outcome. Pediatrics 89:466-469, 1992
38. Alessi DM, Maceri D: Histiocytosis X of the head ans neck in a pediatric population. Arch Otolaryngol Head Neck Surg 118:945-948, 1992
39. Komp DM: Langerhans cell histiocytosis. N Engl J Med 316:747-748, 1987
40. McLelland J, Broadbent V, Yeomans E, et al: Langerhans cell histiocytosis: The case for conservative treatment. Arch Dis Child 65:301-301, 1990
41. Ringden O, Ahstrom L, Lonnqvist B, et al: Allogeneic bone marrow transplant with chemotherapy resistant progressive histiocytosis X. N Engl J Med 316:733-747, 1987
42. Ng C, Lam T, Chan JK, et al: Juvenile chronic myeloid leukemia: A malignancy of S-100 positive histiocytes. Am J Clin Pathol 90:575-582, 1988
43. Egeler RM, Neglia JP, Arico M, et al: Acute leukemia in association with Langerhans cell histiocytosis. Med Pediatr Oncol 23:81-85, 1994
44. Egeler RM, Neglia JP, Puccetti DM, et al: Association of Langerhans cell histiocytosis with malignant neoplasms. Cancer 71:865-873, 1992
45. Sandoval C, Pui C, Bowman LC, et al: Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomeraase II inhibitors, and irradiation. J Clin Oncol 11:1039-1045, 1993
46. Winick NJ, McKenna RW, Shuster JJ, et al: Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide. J Clin Oncol 11:209-217, 1993
47. Horibe K, Matsushita T, Numata S, et al: Acute promyelocytic leukemia with t(15; 17) abnormality after chemotherapy containing etoposide for Langerhans cell histiocytosis. Cancer 72:3723-3726, 1993
48. Haupt R, Comelli A, Rosanda C, et al: Acute myeloid leukemia after single agent treatment with etoposide for Langerhans cell histiocytosis of bone. Am J Pediatr Hematol Oncol 15:255-257, 1993
49. Turgut M, Gurcay O: Multifocal histiocytosis X of bone in two adjacent vertebrae causing paraplegia. Aust NZ J Surg 62:241-244, 1992
50. Rand EB, Whitington PF: Successful orthotopic liver transplantation in two patients with liver failure due to sclerosing cholangitis with Langerhans cell histiocytosis. J Pediatr Castro Nutr 15:202-207, 1992
51. Concepcion W, Esquivel CO, Terry A, et al: Liver transplantation in Langerhans' cell histiocytosis. Semin Oncol 18:24-28, 1991
52. Grois N, Flucher-Wolfran B, Heitger A, et al: Diabetes insipidus in Langerhans cell histiocytosis: Results from the DAL-HX83 study. Med Pediatr Oncol 24:248-256, 1995